Bruton's tyrosine kinase (Btk), a nonreceptor cytoplasmic tyrosine kinase b
elonging to the Tec family of kinases, has been shown to be critical for B
cell proliferation, differentiation, and signaling. Loss-of-function mutati
ons in the Btk gene lead to X-linked agammaglobulinemia (XLA), a primary im
munodeficiency in humans, and the less severe condition xid in mice. Althou
gh Btk is mainly localized in the cytoplasm under steady state conditions,
it translocates to the plasma membrane upon growth factor stimulation and c
rosslinking of the B cell receptor. Nevertheless, in ectopically as well as
endogenously Btk-expressing cells, it can also translocate to the nucleus.
Deletion of the pleckstrin homology (PH) domain (Delta PH1) leads, however
, to an even redistribution of Btk within the nucleus and cytoplasm in the
majority of transfected cells. In contrast, an SH3-deleted (Delta SH3) muta
nt of Btk has been found to be predominantly nuclear. We also demonstrate t
hat the nuclear accumulation of Delta PH1 is dependent on Src expression. T
his nucleocytoplasmic shuttling is sensitive to the exportin 1/CRM1-inactiv
ating drug, leptomycin B, indicating that Btk utilizes functional nuclear e
xport signals. In addition, while the Delta PH1 mutant of Btk was found to
be active and tyrosine-phosphorylated in vivo, Delta SH3 displayed decrease
d autokinase activity and was not phosphorylated. Our findings indicate tha
t the nucleocytoplasmic shuttling of Btk has implications regarding potenti
al targets inside the nucleus, which may be critical in gene regulation dur
ing B cell development and differentiation.